Results of shareholder votes disclosed under 8-K Item 5.07.
Immunocore Holdings plc shareholders approved Receive and adopt U.K. statutory annual accounts and reports for 2025 at the 2026-05-27 meeting.
“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the “2025 U.K. Annual Report”). The votes were cast as follows: For Against Abstain 38,287,987 944 14,909”
Immunocore Holdings plc shareholders approved Authorization to audit committee to determine U.K. statutory auditors’ remuneration for 2026 at the 2026-05-27 meeting.
“Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors’ remuneration for the year ending December 31, 2026. The votes were cast as follows: For Against Abstain 38,293,269 2,481 8,090”
Immunocore Holdings plc shareholders approved Re-appointment of Deloitte LLP as U.K. statutory auditors at the 2026-05-27 meeting.
“Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. The votes were cast as follows: For Against Abstain 38,294,523 966 8,351”
Immunocore Holdings plc shareholders approved Ratification of Deloitte LLP as U.S. independent registered public accounting firm for 2026 at the 2026-05-27 meeting.
“Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2026. The votes were cast as follows: For Against Abstain 38,294,666 984 8,190”
Immunocore Holdings plc shareholders approved Advisory vote on compensation of named executive officers at the 2026-05-27 meeting.
“Resolution 4: To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement. The votes were cast as follows: For Against Abstain 29,682,169 8,600,029 21,642”
Immunocore Holdings plc shareholders approved Re-appointment of Kristine Peterson as director at the 2026-05-27 meeting.
“Resolution 3 : To re-appoint as a director of the Company Kristine Peterson. The votes were cast as follows: For Against Abstain 29,537,800 8,744,383 21,657”
Immunocore Holdings plc shareholders approved Re-appointment of William Pao as director at the 2026-05-27 meeting.
“Resolution 2 : To re-appoint as a director of the Company William Pao, M.D., Ph.D. The votes were cast as follows: For Against Abstain 38,040,755 254,852 8,233”
Immunocore Holdings plc shareholders approved Re-appointment of Siddharth Kaul as director at the 2026-05-27 meeting.
“Resolution 1 : To re-appoint as a director of the Company Siddharth Kaul. The votes were cast as follows: For Against Abstain 38,033,664 261,819 8,357”
NCS Multistage Holdings, Inc. shareholders approved Approve, on an advisory basis, the compensation of the Company’s named executive officers at the 2026-05-27 meeting.
“Proposal 3 — Approve, on an advisory basis, the compensation of named executive officers For 1,938,033 Against 3,111 Abstentions 1,635 Broker Non-Votes 285,928”
NCS Multistage Holdings, Inc. shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-27 meeting.
“Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm For 2,226,925 Against 849 Abstentions 933 Broker Non-Votes —”
NCS Multistage Holdings, Inc. shareholders approved Election of two Class III Directors nominated by the Board of Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified at the 2026-05-27 meeting.
“Proposal 1 — Election of Directors Broker Names For Withheld Non-Votes John Deane 1,800,311 142,468 285,928 W. Matt Ralls 1,858,268 84,511 285,928”
Perspective Therapeutics, Inc. shareholders approved Advisory vote on frequency of advisory stockholder votes on executive compensation at the 2026-05-27 meeting.
“The stockholders of the Company voted, on a non-binding advisory basis, on how frequently future non-binding advisory votes on the compensation of the Company’s named executive officers should be held. The votes were cast as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 76,479,166 274,495 364,497 165,067 20,599,237”
Perspective Therapeutics, Inc. shareholders approved Ratification of appointment of WithumSmith+Brown, PC as independent registered public accounting firm at the 2026-05-27 meeting.
“The stockholders of the Company ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Perspective Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-27 meeting.
“The stockholders of the Company elected Lori A. Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III to the Company’s Board of Directors”
TRINET GROUP, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent auditor at the 2026-05-27 meeting.
“Proposal 3. Stockholders ratified the selection by the Finance and Audit Committee of the Board of Directors of the Company of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Total 41,815,075 582,335 49,978 0 42,447,388”
TRINET GROUP, INC. shareholders approved Advisory vote on executive compensation at the 2026-05-27 meeting.
“Proposal 2. Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes Total 38,448,545 903,509 31,258 3,064,076 42,447,388”
TRINET GROUP, INC. shareholders approved Election of Directors at the 2026-05-27 meeting.
“Proposal 1 . Stockholders elected each of the three nominees below as directors to serve until the Company’s 2029 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified. The voting results were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Total Michael J. Angelakis 38,391,874 991,438 3,064,076 42,447,388 David C. Hodgson 37,885,852 1,497,460 3,064,076 42,447,388 Jacqueline Kosecoff 38,866,465 516,847 3,064,076 42,447,388 Michael Q. Simonds 38,933,678 449,634 3,064,076 42,447,388”
Civeo Corp shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026 and authorization to determine compensation at the 2026-12-31 meeting.
“Proposal 4 - To ratify the appointment of Ernst & Young LLP as Civeo’s independent registered public accounting firm for the year ending December 31, 2026 and until the next annual general meeting of shareholders and to authorize the directors of Civeo, acting through the Audit Committee, to determine the remuneration to be paid to Ernst & Young LLP for 2026: For Withheld Broker Non-Votes 10,096,589 4,228 --”
Civeo Corp shareholders approved Amendment to 2014 Equity Participation Plan to increase shares available by 520,920.
“Proposal 3 – To approve an amendment to the Plan to increase the number of shares available for issuance thereunder by 520,920 shares, subject to adjustment in accordance with the terms of the Plan: For Against Abstain Broker Non-Votes 8,240,482 53,383 310,708 1,496,244”
Civeo Corp shareholders approved Advisory vote on compensation of named executive officers.
“Proposal 2 - To approve, on an advisory basis, the compensation of the named executive officers: For Against Abstain Broker Non-Votes 8,247,893 33,269 323,411 1,496,244”
Civeo Corp shareholders approved Election of the three Class II and Class III nominees to the Board.
“The voting results for each proposal are as follows: Proposal 1 - To elect the three Class II and Class III nominees to the Board: For Withheld Broker Non-Votes Richard A. Navarre 8,406,487 198,086 1,496,244 Martin A. Lambert 8,417,605 186,968 1,496,244 Constance B. Moore 8,418,306 186,267 1,496,244 Bradley J. Dodson 8,572,412 32,161 1,496,244 Daniel B. Silvers 8,293,243 311,330 1,496,244 Timothy O. Wall 8,562,700 41,873 1,496,244”
Nuvation Bio Inc. shareholders approved To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. at the 2026-05-21 meeting.
“Proposal No. 3 - To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.”
Nuvation Bio Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.
“Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Nuvation Bio Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.
“Proposal No. 1 - Election of Directors. The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company’s 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
LTC PROPERTIES INC shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“Proposal No. 3: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of LTC for fiscal 2026, based upon the following votes: For Against Abstentions Broker Non-Votes 38,142,277 1,191,990 95,221 -0-”
LTC PROPERTIES INC shareholders approved Advisory vote on executive compensation at the 2026-05-20 meeting.
“Proposal No. 2: Stockholders approved, on an advisory basis, the compensation of the named executive officers of LTC, based upon the following votes: For Against Abstentions Broker Non-Votes 31,454,030 1,228,903 106,967 6,639,588”
LTC PROPERTIES INC shareholders approved Election of Directors at the 2026-05-20 meeting.
“Proposal No. 1: Stockholders elected six directors to serve on the Board of Directors for the ensuing year and until the election and qualification of their respective successors, based upon the following votes: Director Nominee For Against Abstentions Broker Non-Votes Cornelia Cheng 32,478,949 247,411 63,540 6,639,588 David L. Gruber 32,591,576 146,564 51,760 6,639,588 Jeffrey C. Hawken 32,395,204 329,919 64,777 6,639,588 Bradley J. Preber 32,548,503 173,361 68,036 6,639,588 Wendy L. Simpson 32,285,974 453,380 50,546 6,639,588 Timothy J. Triche, M.D. 31,621,007 1,108,278 60,615 6,639,588”
Apple Hospitality REIT, Inc. shareholders approved Advisory resolution to approve the compensation paid to the Company's named executive officers at the 2026-05-22 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 175,328,993 5,940,374 730,287 20,674,943”
Apple Hospitality REIT, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2026 at the 2026-05-22 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 199,438,485 2,704,182 531,930 -”
Apple Hospitality REIT, Inc. shareholders approved Election of eight directors to the Board of Directors at the 2026-05-22 meeting.
“NOMINEE FOR WITHHELD BROKER NON-VOTES Glenn W. Bunting 177,756,332 4,243,322 20,674,943”
HEALTHCARE SERVICES GROUP INC shareholders approved Shareholder approval to amend the 2020 Omnibus Plan to increase the number of shares of Common Stock that are available for issuance thereunder by 2,500,000 at the 2026-05-26 meeting.
“Proposal No. 4 — Amendment to the 2020 Omnibus Plan The proposal relating to shareholder approval to amend the 2020 Omnibus Plan to increase the number of shares of Common Stock that are available for issuance thereunder by 2,500,000 has received a majority of the votes cast as follows: Votes For Votes Against Abstain Broker Non-Votes 59,690,433 2,747,530 61,769 3,607,184”
HEALTHCARE SERVICES GROUP INC shareholders approved Advisory vote on a non-binding resolution to approve the compensation of the Company's named executive officers (the "Say on Pay Vote") at the 2026-05-26 meeting.
“Proposal No. 2 — Say on Pay Vote The proposal relating to an advisory vote on a non-binding resolution to approve the compensation of the Company's named executive officers (the "Say on Pay Vote") has received a majority of the votes cast as follows: Votes For Votes Against Abstain Broker Non-Votes 61,059,063 1,305,516 135,153 3,607,184”
HEALTHCARE SERVICES GROUP INC shareholders approved Election of nine Directors for a one-year term at the 2026-05-26 meeting.
“Item 5.07 Submission of Matters to a Vote of Security Holders On Tuesday, May 26, 2026, the Company held its annual meeting of shareholders for the purposes of voting on the matters disclosed in its definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 15, 2026.”
Star Equity Holdings, Inc. shareholders approved Ratification of the appointment of Wolf & Company, P.C. as Star's independent registered public accounting firm to audit Star's financial statements for the fiscal year ending December 31, 2026 at the 2026-05-27 meeting.
“Star Equity Holdings, Inc. (“Star”) held its Annual Meeting of Stockholders on May 27, 2026 (the “Annual Meeting”). As of the close of business on March 31, 2026, the record date for the Annual Meeting, there were 3,707,314 shares of Star’s common stock, par value $0.001 per share (the “Common Stock”), outstanding and entitled to vote. A total of 3,176,323 shares of Common Stock were represented in person or by proxy at the Annual Meeting, which constituted a quorum to conduct business at the meeting. At the Annual Meeting, Star’s stockholders: (a) Elected seven directors to serve on Star’s board of directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1); (b) Approved, on a non-binding advisory basis, the compensation of Star’s named executive officers as disclosed in Star’s proxy statement filed on April 30, 2026 (the “Proxy Statement”) (Proposal 2); (c) Ratified the appointment of Wolf & Company, P.C. as Star’s in”
Star Equity Holdings, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of Star's named executive officers as disclosed in Star's proxy statement at the 2026-05-27 meeting.
“Star Equity Holdings, Inc. (“Star”) held its Annual Meeting of Stockholders on May 27, 2026 (the “Annual Meeting”). As of the close of business on March 31, 2026, the record date for the Annual Meeting, there were 3,707,314 shares of Star’s common stock, par value $0.001 per share (the “Common Stock”), outstanding and entitled to vote. A total of 3,176,323 shares of Common Stock were represented in person or by proxy at the Annual Meeting, which constituted a quorum to conduct business at the meeting. At the Annual Meeting, Star’s stockholders: (a) Elected seven directors to serve on Star’s board of directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1); (b) Approved, on a non-binding advisory basis, the compensation of Star’s named executive officers as disclosed in Star’s proxy statement filed on April 30, 2026 (the “Proxy Statement”) (Proposal 2); (c) Ratified the appointment of Wolf & Company, P.C. as Star’s in”
Star Equity Holdings, Inc. shareholders approved Election of seven directors to serve on Star's board of directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified at the 2026-05-27 meeting.
“Star Equity Holdings, Inc. (“Star”) held its Annual Meeting of Stockholders on May 27, 2026 (the “Annual Meeting”). As of the close of business on March 31, 2026, the record date for the Annual Meeting, there were 3,707,314 shares of Star’s common stock, par value $0.001 per share (the “Common Stock”), outstanding and entitled to vote. A total of 3,176,323 shares of Common Stock were represented in person or by proxy at the Annual Meeting, which constituted a quorum to conduct business at the meeting. At the Annual Meeting, Star’s stockholders: (a) Elected seven directors to serve on Star’s board of directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1); (b) Approved, on a non-binding advisory basis, the compensation of Star’s named executive officers as disclosed in Star’s proxy statement filed on April 30, 2026 (the “Proxy Statement”) (Proposal 2); (c) Ratified the appointment of Wolf & Company, P.C. as Star’s in”
PERDOCEO EDUCATION Corp shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-12-31 meeting.
“The Company’s stockholders voted as follows to ratify the selection of Grant Thornton LLP as the independent registered public accounting firm to audit the Company’s financial statements for the year ended December 31, 2026: Votes For: Against: Abstain: 57,810,135 671,429 3,591”
PERDOCEO EDUCATION Corp shareholders approved Nonbinding advisory approval of executive compensation.
“The Company’s stockholders approved, on a nonbinding advisory basis, the executive compensation paid by the Company to its named executive officers, by the votes set forth in the table below: Votes For: Against: Abstain: Broker Non-Votes: 53,091,201 1,058,312 62,196 4,273,446”
PERDOCEO EDUCATION Corp shareholders approved Approval of Perdoceo Education Corporation 2026 Long-Term Incentive Plan.
“The Company’s stockholders approved the Perdoceo Education Corporation 2026 Long-Term Incentive Plan, by the votes set forth in the table below: Votes For: Against: Abstain: Broker Non-Votes: 51,753,505 2,443,873 14,331 4,273,446”
PERDOCEO EDUCATION Corp shareholders approved Election of nine directors to the Company's Board of Directors.
“The Company’s stockholders voted as follows to elect nine directors to the Company’s Board of Directors: Directors: Votes For: Against: Abstain: Broker Non-Votes: Dennis H. Chookaszian 52,077,303 2,131,513 2,893 4,273,446”
Primerica, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-21 meeting.
“Proposal 3: The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. For Against Abstain Broker Non-Votes 28,402,788 100,926 32,266 N/A”
Primerica, Inc. shareholders approved Advisory vote on executive compensation (Say-on-Pay) at the 2026-05-21 meeting.
“Proposal 2: An advisory vote on executive compensation (Say-on-Pay) was approved. For Against Abstain Broker Non-Votes 26,914,943 403,201 33,360 1,184,476”
Primerica, Inc. shareholders voted on Election of Directors at the 2026-05-21 meeting.
“Proposal 1: The following nominees were elected by majority vote to serve on the Board of Directors: Nominee For Against Abstain Broker Non-Votes John A. Addison, Jr. 26,817,258 512,490 21,756 1,184,476 Joel M. Babbit 26,874,390 459,525 17,589 1,184,476 Amber L. Cottle 27,016,062 312,528 22,914 1,184,476 Cynthia N. Day 25,110,328 2,220,778 20,398 1,184,476 Sanjeev Dheer 27,294,427 40,170 16,907 1,184,476 D. Richard Williams 26,364,898 964,215 22,391 1,184,476 Glenn J. Williams 27,048,998 280,624 21,882 1,184,476 Darryl L. Wilson 26,979,554 350,827 21,123 1,184,476 Barbara A. Yastine 26,483,751 847,445 20,308 1,184,476”
WEBSTER FINANCIAL CORP shareholders approved Proposal to approve the adjournment or postponement of the Special Meeting, if necessary or appropriate, to solicit additional proxies at the 2026-05-26 meeting.
“Proposal 3 — Proposal to approve the adjournment or postponement of the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes to approve the Transaction Proposal or to ensure that any supplement or amendment to the accompanying document is timely provided (the “Adjournment Proposal”) FOR AGAINST ABSTAIN 114,010,089 2,963,510 286,357”
WEBSTER FINANCIAL CORP shareholders approved Proposal to approve, on an advisory (non-binding) basis, the compensation payments that will or may be paid to the Company’s named executive officers in connection with the Transaction at the 2026-05-26 meeting.
“Proposal 2 — Proposal to approve, on an advisory (non-binding) basis, the compensation payments that will or may be paid to the Company’s named executive officers in connection with the Transaction (the “Compensation Proposal”) The Company’s stockholders approved, on an advisory (non-binding) basis, the Compensation Proposal as set forth below: FOR AGAINST ABSTAIN 68,045,455 48,130,845 1,083,656”
WEBSTER FINANCIAL CORP shareholders approved Proposal to approve and adopt the Transaction Agreement and the transactions contemplated thereby at the 2026-05-26 meeting.
“Proposal 1 — Proposal to approve and adopt the Transaction Agreement and the transactions contemplated thereby (the “Transaction Proposal”) The Company’s stockholders approved the Transaction Proposal as set forth below: FOR AGAINST ABSTAIN 115,788,667 1,279,203 192,086”
Xerox Holdings Corp shareholders approved Proposal to approve an Amendment to the Company's 2024 Equity and Performance Incentive Plan.
“4. Proposal to approve an Amendment to the Company’s 2024 Equity and Performance Incentive Plan. The Second Amendment to the 2024 Equity and Performance Incentive Plan was approved. For Against Abstain Non-Votes 46,522,213 15,872,321 915,269 24,917,530”
Xerox Holdings Corp shareholders approved Approval, on an advisory basis, of the 2025 compensation of the Company's Named Executive Officers.
“3. Approval, on an advisory basis, of the 2025 compensation of the Company’s Named Executive Officers (“NEOs”), as defined and disclosed in Company’s proxy statement in connection with the 2026 Annual Meeting. The 2025 compensation of the Company’s NEOs was approved, on an advisory basis. For Against Abstain Non-Votes 57,704,131 5,076,884 528,788 24,917,530”
Xerox Holdings Corp shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.
“2. Ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026. The selection of PricewaterhouseCoopers LLP was ratified. For Against Abstain Non-Votes 85,318,113 2,380,846 528,374 0”
Xerox Holdings Corp shareholders approved Election of Directors.
“1. Election of Directors. All nominees for director were elected. Name For Against Abstain Non-Votes John G. Bruno 61,031,963 1,983,261 294,579 24,917,530 Tami A. Erwin 60,879,481 2,112,130 318,192 24,917,530 Priscilla Hung 60,306,508 2,673,724 329,571 24,917,530 Scott Letier 60,763,260 2,230,676 315,867 24,917,530 Nichelle Maynard-Elliott 60,609,204 2,377,772 322,827 24,917,530 Edward G. McLaughlin 60,808,194 2,174,684 326,925 24,917,530 Louis J. Pastor 61,361,965 1,660,009 287,829 24,917,530 John J. Roese 61,134,753 1,859,087 315,963 24,917,530 Amy Schwetz 61,022,748 1,954,945 332,110 24,917,530”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.